Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer: Results from the BCIRG 006 study

1. Au, H.-J.
2. Eiermann, W.
3. Robert, N.J.
4. Pieńkowski, T.
5. Crown, J.
6. Martin, M.
7. Pawlicki, M.
8. Chan, A.
9. Mackey, J.
10. Glaspy, J.
11. Pintér, T.
12. Liu, M.-C.
13. Fornander, T.
14. Sehdev, S.
15. Ferrero, J.-M.
16. Bée, V.
17. Santana, M.J.
18. Miller, D.P.
19. Lalla, D.
20. Slamon, D.J.